Related Experiment Videos
Parenteral nutrition-associated cholestasis.
1University of Michigan Medical School, Ann Arbor, Michigan 48109-0245, USA.
Seminars in Pediatric Surgery
|May 1, 2001
Summary
Cholestasis, a serious complication in short bowel syndrome patients, has unknown causes. Early enteral feeding and bile-flow-inducing agents may help prevent this condition.
Area of Science:
- Gastroenterology and Hepatology
- Intestinal Diseases
- Biliary System Disorders
Background:
- Cholestasis is a frequent and severe complication in patients with short bowel syndrome (SBS).
- It significantly contributes to the morbidity and mortality rates within this patient population.
- The precise etiology of cholestasis in SBS remains unclear, suggesting a multifactorial origin.
Purpose of the Study:
- To review current understanding of cholestasis in short bowel syndrome.
- To discuss emerging mechanistic insights into the development of this complication.
- To provide current recommendations for prevention and management.
Main Methods:
- Literature review of existing studies on cholestasis and short bowel syndrome.
- Synthesis of mechanistic data and clinical observations.
- Discussion of potential therapeutic strategies.
Main Results:
- The exact causes of cholestasis in SBS are not fully understood.
- Multiple factors likely contribute to its development.
- New mechanistic insights are emerging, guiding future research directions.
Conclusions:
- Prompt recognition and early initiation of enteral feeding are crucial.
- Avoiding overfeeding with parenteral nutrition is important.
- Agents that promote bile flow may be beneficial in preventing cholestasis.